Received Jun 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
Customer called and reported that her adult son received VARIVAX as a child, but he recently had a titer which showed no immunity. The customer reports that he is going to receive a booster dose of VARIVAX. She asks if he should receive 1 or 2 doses; This spontaneous report was received from a consumer or other non health professional and refers to a adult male patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On an unknown date (when patient was a child), he was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (dose, route of administration, anatomical location, lot # and expiration date were not reported) as prophylaxis, reconstituted with a sterile diluent (MERCK STERILE DILUENT) (dose, indication, expiration date, and lot # were not reported). On an unknown date (reported as recently), the patient had a titer which showed no immunity (antibody test negative). In addition, it was informed that he was going to receive a booster dose of the suspect vaccine and asked if he should receive 1 or 2 doses. At the reporting time, the patient had not recovered from the event. The causal relationship between the event and the suspect vaccine was not provided. Additional information is not expected.
Sterile diluent